Option Care Health (NASDAQ: OPCH) boosts 2025 share repurchase to $1B
Rhea-AI Filing Summary
Option Care Health, Inc. disclosed that its board of directors has increased the authorization for its 2025 share repurchase program from $500 million to $1 billion, with no specified expiration date. The company may buy back stock through open market purchases, privately negotiated transactions, block trades, or accelerated and other structured repurchase programs, with volume and timing determined by management based on market, regulatory, and corporate factors.
The company also furnished a press release with preliminary financial results for the three and twelve months ended December 31, 2025 and preliminary expectations for full year 2026, and an investor presentation tied to its appearance at the 44th Annual J.P. Morgan Healthcare Conference.
Positive
- Share repurchase authorization expanded from
$500 million to$1 billion , indicating a significantly larger board-approved capacity for returning capital via buybacks.
Negative
- None.
Insights
Option Care Health doubles its 2025 buyback authorization to $1B.
Option Care Health reports that its board approved increasing the 2025 share repurchase program authorization from
A larger, open-ended authorization gives management flexibility to repurchase shares when they judge conditions to be attractive, subject to market conditions, regulatory requirements, and other corporate considerations. The filing does not commit the company to repurchase a specific amount, so actual capital returned will depend on future management decisions and market dynamics.
The company also furnished preliminary financial results for the three and twelve months ended December 31, 2025, preliminary expectations for full year 2026, and an investor presentation for the
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) |
(IRS Employer Identification Number) |
| (Address of principal executive offices) |
(
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Securities registered pursuant to Section 12(b) of the Act:
| Title of each Class | Trading Symbol(s) | Name of each exchange on which registered | ||
Item 2.02. Results of Operations and Financial Condition.
On January 12, 2026, Option Care Health, Inc. (the “Company”) issued a press release announcing its preliminary financial results for the three and twelve months ended December 31, 2025 and preliminary financial expectations for full year 2026. A copy of the press release is furnished with this Current Report on Form 8-K (this “Report”) and attached hereto as Exhibit 99.1.
Item 7.01. Regulation FD Disclosure.
In connection with its participation at the 44th Annual J.P. Morgan Healthcare Conference, the Company will present on January 13, 2026. A copy of the Company's presentation is furnished with this Report as Exhibit 99.2.
The information under Items 2.02 and 7.01 of this Report and the exhibits referenced therein shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 8.01. Other Events.
On January 9, 2026, the Company’s Board of Directors approved an increase to its 2025 share repurchase program authorization from $500 million to $1 billion. This program has no specified expiration date. Shares may be repurchased under the program through open market purchases, privately negotiated transactions, block trades, or accelerated or other structured share repurchase programs. The extent to which the Company repurchases shares, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other corporate considerations, as determined by the Company’s management.
Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
| Exhibit Number |
Exhibit Description | |
| 99.1 | Press Release dated January 12, 2026 | |
| 99.2 | Investor Presentation dated January 13, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Option Care Health, Inc. | |||
| Date: | January 12, 2026 | By: | /s/ Meenal Sethna |
| Meenal Sethna | |||
| Chief Financial Officer |
FAQ
What did Option Care Health (OPCH) announce regarding its share repurchase program?
How can Option Care Health (OPCH) execute its expanded share repurchase program?
What factors will influence the timing and extent of OPCH share repurchases?
Did Option Care Health provide preliminary financial results in this 8-K?
What upcoming investor event is Option Care Health participating in?
Are the preliminary results and investor presentation in this OPCH filing considered filed or furnished?
